Breaking Bottlenecks: Data-Driven Manufacturing and Case Management in Autologous Cell Therapy
Abstract: CAR-T therapies have proven their curative potential, but cell therapy developers continue to face challenges related to manufacturing complexities, costs, scalability, regulatory compliance, and supply chain management. To achieve success and drive cost efficiencies in cell therapy programs, two critical strategies are the adoption of data-driven manufacturing and the implementation of comprehensive, end-to-end orchestration of supply chain logistics. This session will offer actionable insights into how data and case management can unlock scalability and cost savings.